Evidence type: Human RCT | Observational | Animal | In vitro | Regulatory Mechanism of Action As a copper chelator, GHK-Cu modulates over 4,000 human genes, upregulating those involved in tissue remodeling (e.g., collagen I, III) and downregulating pro-inflammatory pathways like NF-B
Stored properly in its sealed vial at cool temperatures, lyophilized BPC-157 can remain stable for months or even years
Every dose in the standard escalation protocol stays measurable on a standard insulin syringe
Individual Variability: Responses to supplements can vary significantly between individuals due to genetic, lifestyle, and health status differences
Glucagon-like peptide-1 receptor agonists and dual glucose-dependent insulinotropic polypeptide/glucagon-like peptide-1 receptor agonists in the treatment of obesity/metabolic syndrome, prediabetes/diabetes and non-alcoholic fatty liver disease-current evidence
Starting weight, metabolic health, and cardiovascular sensitivity can change both exposure and side effects at the same nominal dose
